Comparison of metformin and insulin in the treatment of gestational diabetes: a retrospective, case-control study.
OBJECTIVE
Limited data are available on metformin therapy in gestational diabetes. The aim of the study was to compare maternal and neonatal outcomes in patients with gestational diabetes mellitus (GDM) treated with metformin with those treated with insulin, or diet alone.


METHODS
We conducted a retrospective study that included 45 GDM women treated with metformin, 45 women treated with insulin and 83 women with no pharmacological treatment. Subjects were matched for pre-pregnancy body mass index (BMI) and age.


RESULTS
There were no differences between the metformin-treated group and the other two groups in terms of maternal outcomes (total weight gain during pregnancy or after the diagnosis of GDM, pre-pregnancy hypertension, pregnancy induced hypertension, pre-eclampsia etc.). In the diagnostic 2-hour oral glucose tolerance test, glucose values were slightly, but significantly, higher in the insulin group than in the metformin group (p < 0.003). Eighteen percent of mothers treated with metformin needed supplementary insulin therapy. No differences between the metformin-treated group and the other two groups (insulin, diet only) were observed in relation to mean birth weights, prevalence of macrosomia, or gestational weeks at delivery. The incidence of neonatal hypoglycemia was higher in the insulin group than in the metformin group (p = 0.03). There were no differences between the groups in other neonatal outcomes (small for gestational age, Apgar scores, umbilical artery pH or base excess, etc.).


CONCLUSIONS
These retrospective data suggest that metformin is effective in controlling gestational diabetes and is not associated with a higher risk of maternal or neonatal complications compared with insulin.
Tertti
Kristiina
K
Department of Obstetrics and Gynecology, Turku University Central Hospital, Turku, Finland.
Ekblad
Ulla
U
Vahlberg
Tero
T
Rönnemaa
Tapani
T
Fertil Steril. 2006 Sep;86(3):658-63
16879826
J Clin Endocrinol Metab. 2002 Feb;87(2):524-9
11836280
Curr Diab Rep. 2003 Aug;3(4):303-12
12866993
Am J Obstet Gynecol. 2000 Jul;183(1):S1-S22
10920346
Diabetes Care. 2002 Oct;25(10):1862-8
12351492
Fertil Steril. 2002 Mar;77(3):520-5
11872206
N Engl J Med. 2008 May 8;358(19):2003-15
18463376
Clin Obstet Gynecol. 2007 Dec;50(4):959-71
17982339
N Engl J Med. 2005 Jun 16;352(24):2477-86
15951574
Fertil Steril. 2001 Jan;75(1):46-52
11163815
Eur J Obstet Gynecol Reprod Biol. 2008 Jan;136(1):29-33
17350747
Obstet Gynecol Surv. 2004 Feb;59(2):118-27
14752300
Ann Intern Med. 2002 Jul 2;137(1):25-33
12093242
Am J Obstet Gynecol. 2006 Oct;195(4):1081-5
16824464
Diabet Med. 2000 Jul;17(7):507-11
10972579
N Engl J Med. 1999 Dec 2;341(23):1749-56
10580075
BMJ. 1995 Jan 14;310(6972):83-8
7833731
JAMA. 2001 Nov 28;286(20):2516-8
11722247
J Reprod Med. 2007 Nov;52(11):1011-5
18161398
Diabet Med. 2004 Aug;21(8):829-36
15270785
Diabet Med. 2004 Feb;21(2):103-13
14984444